Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transient myeloproliferative disorder in children with <scp>D</scp>own syndrome: clarity to this enigmatic disorder

12 Sept 2012

Abstract excerpt

Children with trisomy 21 have a unique predisposition to develop a megakaryoblastic proliferative disease of varying severity during their first 3 months of life. This disorder exists in no other children or adults without the presence of trisomy 21 and only occurs in the fetal or neonatal period of life. Its spontaneous resolution in most cases further delineates it from otherwise indistinguishable neonatal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Chronic Lymphocytic Leukemia Research
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22966823
DOI: 10.1111/bjh.12041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transient myeloproliferative disorder in children with <scp>D</scp>own syndrome: clarity to this enigmatic disorderPMID 22966823Read ↗

Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.Semantic proximity Read ↗

Clinical, cytogenetic, and molecular analyses of 17 neonates with transient abnormal myelopoiesis and nonconstitutional trisomy 21.Semantic proximity Read ↗

Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.Semantic proximity Read ↗

Haematopoietic development and leukaemia in <scp>D</scp>own syndromeSemantic proximity Read ↗

Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome.Semantic proximity Read ↗

Mechanistic insights into the developmental origin of pediatric hematologic disordersSemantic proximity Read ↗

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.Semantic proximity Read ↗

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.Semantic proximity Read ↗

Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation.Semantic proximity Read ↗

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an UpdateSemantic proximity Read ↗

Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.Semantic proximity Read ↗

A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.